SCHEMBL24754575

SCHEMBL24754575

CCCCNCCC[C@H](NC(=O)C(CC)CCCC)C(=O)NCCCC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.51
▸ CA2 P00918 6/20 0.49
▸ CA1 P00915 4/20 0.49
▸ SIRT6 Q8N6T7 1/20 0.46
▸ SIRT1 Q96EB6 1/20 0.46
▸ DPP7 Q9UHL4 1/20 0.42
▸ CTSS P25774 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.39
▸ NMT2 O60551 1/20 0.38
▸ NMT1 P30419 1/20 0.38
▸ GRIA1 P42261 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21019823 0.86 USP2 (0.49) USP2CA2CA1SIRT6SIRT1
SCHEMBL29849120 0.84 USP2 (0.50) USP2CA2CA1SIRT6SIRT1
SCHEMBL10066206 0.84 USP2 (0.50) USP2CA2CA1SIRT6SIRT1
SCHEMBL24754576 0.84 USP2 (0.50) USP2CA2CA1SIRT6SIRT1
SCHEMBL21020203 0.83 USP2 (0.49) USP2CA2CA1SIRT6SIRT1
SCHEMBL21020133 0.82 GLP1R (0.50) USP2CA2CA1SIRT6SIRT1
SCHEMBL5491789 0.81 USP2 (0.71) USP2CA2CA1DPP7MAPK1
SCHEMBL11692574 0.80 USP2 (0.69) USP2CA2CA1DPP7MAPK1
SCHEMBL22414705 0.76 USP2 (0.69) USP2CA2CA1DPP7MAPK1
SCHEMBL2344008 0.76 CA2 (0.47) USP2CA2CA1DPP7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265338-A1 SILICON SUBSTITUTE COMPOSITION FOR REALIZING FEELING OF USE OF SILICON-BASED COSMETIC COMPONENT 주식회사 진영바이오 2022-12-22 — — WO disclosed
Send feedback